DI VEROLI, AMBRA
DI VEROLI, AMBRA
Azacytidine for the treatment of retrospective analysis from the Gruppo Laziale for the study of Ph-negative MPN
2015-08-01 Andriani, A; Montanaro, M; Voso, Mt; Villivà, N; Ciccone, F; Andrizzi, C; De Gregoris, C; DI VEROLI, A; Maurillo, L; Alimena, G; Latagliata, R
CD34 + CD38-CLL1+ leukemic stem cells persistence measured by multiparametric flow cytometry is a biomarker of poor prognosis in adult patients with acute myeloid leukemia
2021-11-21 Palmieri, R; Buccisano, F; Arena, V; Irno Consalvo, Ma; Piciocchi, A; Maurillo, L; Delprincipe, Mi; Di Veroli, A; Paterno, G; Conti, C; Fraboni, D; Voso, Mt; Arcese, W; Venditti, A
Cytotoxicity and differentiating effect of the poly(ADP-ribose) polymerase inhibitor olaparib in myelodysplastic syndromes
2019-01-01 Faraoni, I; Consalvo, Mi; Aloisio, F; Fabiani, E; Giansanti, M; Di Cristino, F; Falconi, G; Tentori, L; Di Veroli, A; Curzi, P; Maurillo, L; Niscola, P; Lo-Coco, F; Graziani, G; Voso, Mt
Diabetic retinopathy and age-related macular degeneration: A survey of pharmacoutilization and cost in Calabria, Italy
2019-01-01 Scuteri, D; Vero, A; Zito, M; Naturale, Md; Bagetta, G; Nucci, C; Tonin, P; Corasaniti, Mt
Erythropoietin levels and erythroid differentiation parameters in patients with lower-risk myelodysplastic syndromes
2018-01-01 Gurnari, C; Latagliata, R; Buccisano, F; Piciocchi, A; Fenu, S; Mancini, S; Fianchi, L; Criscuolo, M; Sarlo, C; Romano, A; Falconi, G; Niscola, P; Di Veroli, A; Breccia, M; Piccioni, A; Aloe-Spiriti, Ma; Lo-Coco, F; Voso, Mt
Genetic analysis of erythrocytosis reveals possible causative and modifier gene mutations
2019-01-01 Gurnari, C; Lombardi, Am; Cosi, E; Biagetti, G; Buccisano, F; Franceschini, L; Di Veroli, A; Falconi, G; Fabiani, E; Cantonetti, M; Nasso, D; Lo-Coco, F; Randi, Ml; Voso, Mt
Identification of Predictive Factors for Overall Survival and Response during Hypomethylating Treatment in Very Elderly (≥75 Years) Acute Myeloid Leukemia Patients: A Multicenter Real-Life Experience
2022-10-06 Molica, M; Mazzone, C; Niscola, P; Carmosino, I; Di Veroli, A; De Gregoris, C; Bonanni, F; Perrone, S; Cenfra, N; Fianchi, L; Piccioni, Al; Spadea, A; Luzi, G; Mengarelli, A; Cudillo, L; Maurillo, L; Pagano, L; Breccia, M; Rigacci, L; De Fabritiis, P
Infectious disease ward admission positively influences P. jiroveci pneumonia (PjP) outcome: A retrospective analysis of 116 HIV-positive and HIV-negative immunocompromised patients
2017-01-01 Ricciardi, A; Gentilotti, E; Coppola, L; Maffongelli, G; Cerva, C; Malagnino, V; Mari, A; DI VEROLI, A; Berrilli, F; Apice, F; Toschi, N; DI CAVE, D; Giuseppe Parisi, S; Andreoni, M; Sarmati, L
Minimal residual disease as a biomarker for outcome prediction and therapy optimization in acute myeloid leukemia
2018-01-01 Buccisano, F; Maurillo, L; Del Principe, Mi; Di Veroli, A; De Bellis, E; Biagi, A; Zizzari, A; Rossi, V; Rapisarda, V; Amadori, S; Voso, Mt; Lo-Coco, F; Arcese, W; Venditti, A
Minimal Residual Disease in Acute Myeloid Leukemia of Adults: Determination, Prognostic Impact and Clinical Applications
2016-10-20 DEL PRINCIPE, Mi; Buccisano, F; Maurillo, L; Sconocchia, G; Cefalo, M; Consalvo, M; Sarlo, C; Conti, C; De Santis, G; De Bellis, E; DI VEROLI, A; Palomba, P; Attrotto, C; Zizzari, A; Paterno, G; Voso, Mt; DEL POETA, G; LO COCO, F; Arcese, W; Amadori, S; Venditti, A
Myelodysplastic syndromes with del(5q): A real-life study of determinants of long-term outcomes and response to lenalidomide
2022-01-01 Gurnari, C; Piciocchi, A; Soddu, S; Bonanni, F; Scalzulli, E; Niscola, P; Di Veroli, A; Piccioni, Al; Piedimonte, M; Maiorana, G; Salutari, P; Cicconi, L; Santopietro, M; Gumenyuk, S; Sarlo, C; Fenu, S; Tafuri, A; Latagliata, R; Fianchi, L; Criscuolo, M; Maciejewski, Jp; Maurillo, L; Buccisano, F; Breccia, M; Voso, Mt
Pre-transplant persistence of minimal residual disease does not contraindicate allogeneic stem cell transplantation for adult patients with acute myeloid leukemia
2017-03-01 Buccisano, F; Maurillo, L; Piciocchi, A; DEL PRINCIPE, Mi; Picardi, A; Cerretti, R; Cudillo, L; De Angelis, G; Sarlo, C; Cefalo, M; Ditto, C; DI VEROLI, A; Mariotti, B; Nasso, D; De Bellis, E; DEL POETA, G; Voso, Mt; Sconocchia, G; LO COCO, F; Arcese, W; Amadori, S; Venditti, A
Quality-of-life monitoring during hematopoietic stem cell transplantation: observations and a suggestion from the rome transplant network quality of life working party
2013-04-01 Tendas, A; Pignatelli, Ac; Sollazzo, F; Veggia, B; Conte, E; D'Apolito, A; Di Veroli, A; Molinari, V; Mauroni, M; Annibali, O; Pilozzi, V; Cacciaraichi, S; Viggiani, C; Niscola, P; de Fabritiis, P; Arcese, W
Recurrence of a t(8;21)-positive acute myeloid leukemia in the form of a granulocytic sarcoma involving cranial bones: a diagnostic and therapeutic challenge
2013-09-13 DI VEROLI, A; Micarelli, A; Cefalo, M; Ceresoli, E; Nasso, D; Cicconi, L; Mauramati, S; Ottaviani, F; Venditti, A; Amadori, S
Reversible hyporegenerative anemia during natalizumab treatment
2014-09-03 Monteleone, F; Buccisano, F; Boffa, L; Buttari, F; DI VEROLI, A; Borriello, G; Rossi, S; Centonze, D
The emerging role of measurable residual disease detection in AML in morphologic remission
2019-04-01 Buccisano, F; Maurillo, L; Schuurhuis, Gj; Del Principe, Mi; Di Veroli, A; Gurnari, C; Venditti, A
The emerging role of measurable residual disease detection in AML in morphologic remission
2019-01-01 Buccisano, F; Maurillo, L; Schuurhuis, Gj; Del Principe, Mi; Di Veroli, A; Gurnari, C; Venditti, A
Treatment of low-blast count AML using hypomethylating agents
2017-01-01 De Bellis, E; Fianchi, L; Buccisano, F; Criscuolo, M; Maurillo, L; Cicconi, L; Brescini, M; DEL PRINCIPE, Mi; DI VEROLI, A; Venditti, A; Amadori, S; Arcese, W; LO COCO, F; Voso, Mt
Treatment of Philadelphia-negative myeloproliferative neoplasms in accelerated/blastic phase with azacytidine. Clinical results and identification of prognostic factors
2019-01-01 Andriani, A; Elli, E; Trape, G; Villiva, N; Fianchi, L; Di Veroli, A; Niscola, P; Centra, A; Anaclerico, B; Montanaro, G; Martini, V; Aroldi, A; Carmosino, I; Voso, Mt; Breccia, M; Montanaro, M; Foa, R; Latagliata, R
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 1-ago-2015 | Azacytidine for the treatment of retrospective analysis from the Gruppo Laziale for the study of Ph-negative MPN | Andriani, A; Montanaro, M; Voso, Mt; Villivà, N; Ciccone, F; Andrizzi, C; De Gregoris, C; DI VEROLI, A; Maurillo, L; Alimena, G; Latagliata, R | Articolo su rivista | |
| 21-nov-2021 | CD34 + CD38-CLL1+ leukemic stem cells persistence measured by multiparametric flow cytometry is a biomarker of poor prognosis in adult patients with acute myeloid leukemia | Palmieri, R; Buccisano, F; Arena, V; Irno Consalvo, Ma; Piciocchi, A; Maurillo, L; Delprincipe, Mi; Di Veroli, A; Paterno, G; Conti, C; Fraboni, D; Voso, Mt; Arcese, W; Venditti, A | Articolo su rivista | |
| 1-gen-2019 | Cytotoxicity and differentiating effect of the poly(ADP-ribose) polymerase inhibitor olaparib in myelodysplastic syndromes | Faraoni, I; Consalvo, Mi; Aloisio, F; Fabiani, E; Giansanti, M; Di Cristino, F; Falconi, G; Tentori, L; Di Veroli, A; Curzi, P; Maurillo, L; Niscola, P; Lo-Coco, F; Graziani, G; Voso, Mt | Articolo su rivista | |
| 1-gen-2019 | Diabetic retinopathy and age-related macular degeneration: A survey of pharmacoutilization and cost in Calabria, Italy | Scuteri, D; Vero, A; Zito, M; Naturale, Md; Bagetta, G; Nucci, C; Tonin, P; Corasaniti, Mt | Articolo su rivista | |
| 1-gen-2018 | Erythropoietin levels and erythroid differentiation parameters in patients with lower-risk myelodysplastic syndromes | Gurnari, C; Latagliata, R; Buccisano, F; Piciocchi, A; Fenu, S; Mancini, S; Fianchi, L; Criscuolo, M; Sarlo, C; Romano, A; Falconi, G; Niscola, P; Di Veroli, A; Breccia, M; Piccioni, A; Aloe-Spiriti, Ma; Lo-Coco, F; Voso, Mt | Articolo su rivista | |
| 1-gen-2019 | Genetic analysis of erythrocytosis reveals possible causative and modifier gene mutations | Gurnari, C; Lombardi, Am; Cosi, E; Biagetti, G; Buccisano, F; Franceschini, L; Di Veroli, A; Falconi, G; Fabiani, E; Cantonetti, M; Nasso, D; Lo-Coco, F; Randi, Ml; Voso, Mt | Articolo su rivista | |
| 6-ott-2022 | Identification of Predictive Factors for Overall Survival and Response during Hypomethylating Treatment in Very Elderly (≥75 Years) Acute Myeloid Leukemia Patients: A Multicenter Real-Life Experience | Molica, M; Mazzone, C; Niscola, P; Carmosino, I; Di Veroli, A; De Gregoris, C; Bonanni, F; Perrone, S; Cenfra, N; Fianchi, L; Piccioni, Al; Spadea, A; Luzi, G; Mengarelli, A; Cudillo, L; Maurillo, L; Pagano, L; Breccia, M; Rigacci, L; De Fabritiis, P | Articolo su rivista | |
| 1-gen-2017 | Infectious disease ward admission positively influences P. jiroveci pneumonia (PjP) outcome: A retrospective analysis of 116 HIV-positive and HIV-negative immunocompromised patients | Ricciardi, A; Gentilotti, E; Coppola, L; Maffongelli, G; Cerva, C; Malagnino, V; Mari, A; DI VEROLI, A; Berrilli, F; Apice, F; Toschi, N; DI CAVE, D; Giuseppe Parisi, S; Andreoni, M; Sarmati, L | Articolo su rivista | |
| 1-gen-2018 | Minimal residual disease as a biomarker for outcome prediction and therapy optimization in acute myeloid leukemia | Buccisano, F; Maurillo, L; Del Principe, Mi; Di Veroli, A; De Bellis, E; Biagi, A; Zizzari, A; Rossi, V; Rapisarda, V; Amadori, S; Voso, Mt; Lo-Coco, F; Arcese, W; Venditti, A | Articolo su rivista | |
| 20-ott-2016 | Minimal Residual Disease in Acute Myeloid Leukemia of Adults: Determination, Prognostic Impact and Clinical Applications | DEL PRINCIPE, Mi; Buccisano, F; Maurillo, L; Sconocchia, G; Cefalo, M; Consalvo, M; Sarlo, C; Conti, C; De Santis, G; De Bellis, E; DI VEROLI, A; Palomba, P; Attrotto, C; Zizzari, A; Paterno, G; Voso, Mt; DEL POETA, G; LO COCO, F; Arcese, W; Amadori, S; Venditti, A | Articolo su rivista | |
| 1-gen-2022 | Myelodysplastic syndromes with del(5q): A real-life study of determinants of long-term outcomes and response to lenalidomide | Gurnari, C; Piciocchi, A; Soddu, S; Bonanni, F; Scalzulli, E; Niscola, P; Di Veroli, A; Piccioni, Al; Piedimonte, M; Maiorana, G; Salutari, P; Cicconi, L; Santopietro, M; Gumenyuk, S; Sarlo, C; Fenu, S; Tafuri, A; Latagliata, R; Fianchi, L; Criscuolo, M; Maciejewski, Jp; Maurillo, L; Buccisano, F; Breccia, M; Voso, Mt | Articolo su rivista | |
| 1-mar-2017 | Pre-transplant persistence of minimal residual disease does not contraindicate allogeneic stem cell transplantation for adult patients with acute myeloid leukemia | Buccisano, F; Maurillo, L; Piciocchi, A; DEL PRINCIPE, Mi; Picardi, A; Cerretti, R; Cudillo, L; De Angelis, G; Sarlo, C; Cefalo, M; Ditto, C; DI VEROLI, A; Mariotti, B; Nasso, D; De Bellis, E; DEL POETA, G; Voso, Mt; Sconocchia, G; LO COCO, F; Arcese, W; Amadori, S; Venditti, A | Articolo su rivista | |
| 1-apr-2013 | Quality-of-life monitoring during hematopoietic stem cell transplantation: observations and a suggestion from the rome transplant network quality of life working party | Tendas, A; Pignatelli, Ac; Sollazzo, F; Veggia, B; Conte, E; D'Apolito, A; Di Veroli, A; Molinari, V; Mauroni, M; Annibali, O; Pilozzi, V; Cacciaraichi, S; Viggiani, C; Niscola, P; de Fabritiis, P; Arcese, W | Articolo su rivista | |
| 13-set-2013 | Recurrence of a t(8;21)-positive acute myeloid leukemia in the form of a granulocytic sarcoma involving cranial bones: a diagnostic and therapeutic challenge | DI VEROLI, A; Micarelli, A; Cefalo, M; Ceresoli, E; Nasso, D; Cicconi, L; Mauramati, S; Ottaviani, F; Venditti, A; Amadori, S | Articolo su rivista | |
| 3-set-2014 | Reversible hyporegenerative anemia during natalizumab treatment | Monteleone, F; Buccisano, F; Boffa, L; Buttari, F; DI VEROLI, A; Borriello, G; Rossi, S; Centonze, D | Articolo su rivista | |
| 1-apr-2019 | The emerging role of measurable residual disease detection in AML in morphologic remission | Buccisano, F; Maurillo, L; Schuurhuis, Gj; Del Principe, Mi; Di Veroli, A; Gurnari, C; Venditti, A | Articolo su rivista | |
| 1-gen-2019 | The emerging role of measurable residual disease detection in AML in morphologic remission | Buccisano, F; Maurillo, L; Schuurhuis, Gj; Del Principe, Mi; Di Veroli, A; Gurnari, C; Venditti, A | Articolo su rivista | |
| 1-gen-2017 | Treatment of low-blast count AML using hypomethylating agents | De Bellis, E; Fianchi, L; Buccisano, F; Criscuolo, M; Maurillo, L; Cicconi, L; Brescini, M; DEL PRINCIPE, Mi; DI VEROLI, A; Venditti, A; Amadori, S; Arcese, W; LO COCO, F; Voso, Mt | Articolo su rivista | |
| 1-gen-2019 | Treatment of Philadelphia-negative myeloproliferative neoplasms in accelerated/blastic phase with azacytidine. Clinical results and identification of prognostic factors | Andriani, A; Elli, E; Trape, G; Villiva, N; Fianchi, L; Di Veroli, A; Niscola, P; Centra, A; Anaclerico, B; Montanaro, G; Martini, V; Aroldi, A; Carmosino, I; Voso, Mt; Breccia, M; Montanaro, M; Foa, R; Latagliata, R | Articolo su rivista |